Neha Mehta-Shah, MD, MSCI

Articles by Neha Mehta-Shah, MD, MSCI

Chadi Nabhan, MD, MBA, FACPMeeting News | June 7, 2023
The study compared nivolumab plus AVD with brentuximab vedotin plus AVD in advanced stage classic Hodgkin lymphoma.
Cecilia BrownMeeting News | January 10, 2023
Neha Mehta-Shah, MD, MSCI, discusses bispecific antibodies in B-cell lymphomas.